AfricaNews
Trending

Combating Counterfeit Pharmaceuticals: NAFDAC's Vigilance and Action

NAFDAC implements measures to stop influx of counterfeit pharmaceuticals, intercepts over 140 fake products, plans digital authentication

The National Agency for Food and Drug Administration and Control (NAFDAC) has implemented measures to curb the influx of imported pharmaceutical products with counterfeit certificates.

Prof. Mojisola Adeyeye, the agency’s Director-General, announced this during a stakeholders’ engagement meeting held yesterday in Abuja.

Adeyeye highlighted that NAFDAC’s pre-testing system has successfully intercepted over 140 products bearing fake Certificates of Pharmaceutical Products (CPP) from entering the country.

READ ALSO: 50% Imported Pharmaceutical Products in Nigeria are Fake–NAFDAC 

She explained, “We have 55 countries in Africa and are part of the Member States globally. We have committed to ensuring that products entering the region meet quality standards. The World Health Organization (WHO) established a scheme called the Certificate of Pharmaceutical Product, which signifies our assurance to receiving countries regarding the quality of the products.”

“Most of our medicines originate from Southeast Asia, and we are also part of the member states in that region. To ensure quality assurance, we have implemented a pre-shipment testing scheme accompanied by CPP. However, this has not been consistently upheld, as our system has intercepted over 140 approved products from entering,” Adeyeye added.

Prof. Adeyeye further disclosed that NAFDAC plans to digitize the authentication process of these certificates to minimize the prevalence of counterfeit pharmaceutical products in the market.

At the heart of NAFDAC’s efforts to combat counterfeit pharmaceuticals is a steadfast commitment to quality standards and regulatory compliance. Prof. Mojisola Adeyeye, the Director-General of NAFDAC, has been vocal in emphasizing the agency’s dedication to upholding the highest standards of safety and efficacy in the pharmaceutical industry. Through rigorous pre-testing procedures and stringent regulatory oversight, NAFDAC has successfully prevented the entry of counterfeit products into the Nigerian market, safeguarding the health and well-being of millions of Nigerians.

NAFDAC’s relentless efforts to combat counterfeit pharmaceuticals have yielded tangible results, with numerous success stories underscoring the agency’s effectiveness in safeguarding public health. One notable example is the agency’s pre-testing system, which has proven instrumental in preventing the entry of counterfeit products into the country. By subjecting pharmaceutical products to rigorous testing and certification procedures before they are allowed to enter the Nigerian market, NAFDAC has created a formidable barrier against counterfeiters, ensuring that only safe and genuine products reach consumers.

In the fight against counterfeit pharmaceuticals, NAFDAC stands as a beacon of hope and resilience, tirelessly working to protect the health and well-being of Nigerians. Through a combination of enforcement actions, technological innovations, and a steadfast commitment to quality standards, NAFDAC is making significant strides in disrupting the supply chain of counterfeit drugs and ensuring that only safe and genuine products reach consumers. As the agency continues to evolve and adapt to new challenges, it remains steadfast in its mission to safeguard public health and safety, leaving no stone unturned in its pursuit of a counterfeit-free healthcare landscape.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button